AAIC is the largest international forum to advance dementia science and clinical practice. It is the destination where the global dementia community gathers to share breakthroughs, accelerate progress and shape the future of the field. Highlight your work in front of dementia researchers from around the globe and bring key opinion leaders together to impact the future of the field. Opportunities to present in person and online are available.
Individual abstract submissions provide an opportunity for presenting authors to share and discuss designs, data and analyses with AAIC attendees. The following abstract types are eligible for submission to AAIC:
Original: The abstract primarily contains new designs, data or analyses that will not be published or presented prior to AAIC 2027.
Update: The abstract provides updates on designs, data or analyses that have been published or presented prior to AAIC 2027.
Encore: The same or nearly identical abstract content will be published prior to AAIC 2027. Please note, encore abstracts will not be published in Alzheimer’s & Dementia®: The Journal of the Alzheimer’s Association.
“Published” refers to publication in a journal as a full article or conference abstract, or publication on a
preprint server, while “Presented” refers to presentation at a regional, national or international
conference. If your abstract is currently under review, please select the category your abstract meets at the time of
submission then email abstracts@alz.org to change category
upon publication.
Individual abstracts can be submitted for consideration for an oral and/or a poster presentation, with
original, update, and encore abstracts all eligible for oral or poster presentations. Abstracts first undergo peer
review that considers the quality of and interest in the abstract. Then, informed by the peer review scores, the
Scientific Program Committee (SPC) selects certain abstracts for oral presentations. The presenting author of an abstract may attend either in-person or virtually for either oral or poster presentations.
AAIC allows for the thoughtful use of artificial intelligence (AI) in abstract preparation; however, submitters will be asked to disclose usage in the abstract submission process. AAIC follows AI guidance and best practices used by the Alzheimer’s & Dementia journal family. Read the best practice guidelines on the use of AI in your research and abstract preparation. Use of automated assistive writing technologies, generative AI or machine learning tools must be disclosed. It is the submitter’s responsibility to ensure accuracy and scientific integrity of their content. Please view the AAIC Guide to Submissions (PDF) for full guidance on the use of AI in abstract preparation.
Submit Your Art or Reflections to Beyond the Data
Beyond the Data celebrates the people and experiences behind Alzheimer’s and dementia research. Through visual art, writing and personal or professional reflection, this initiative highlights the human connections that inspire scientific discovery, offering a more holistic view of science as a deeply human endeavor.
Work submitted for Beyond the Data should be original/unpublished and prepared by the presenting author. Images can include research figures (e.g. neuroimaging analysis, immunohistochemistry, brain autoradiography, electron microscopy), illustrations and photography. All submissions will undergo peer-review, and accepted work will be displayed as part of the poster presentations at AAIC 2027.
A select number of visual art submissions may be shortlisted for the Beyond the Data: Art Competition, held at the ISTAART Reception, where attendees are invited to vote for the best image. Shortlisted submissions will be notified prior to the reception, not all entries are automatically entered into the competition. The winner receives a conference fellowship for the following AAIC.
Pictured: "The Timeless Connection" by Lavinia Perquim
Submit a Session Proposal to AAIC
You can also organize and submit a session proposal and help shape the program at AAIC.
Featured Research Sessions (FRS)
debut and discuss innovative and impactful research findings, drawing together multiple studies that share a common focus.
FRS are 90 minutes in length and comprise 2 chairs and 4-6 presenters, with each presenter submitting a structured abstract. Original, update and encore abstracts are all eligible for inclusion.
The chairs of featured research sessions are akin to journal editors for a special issue, who invite presenting authors to share their latest study findings.
If an FRS is not accepted, abstracts that receive an appropriate average score are automatically considered by the Scientific Program Committee for an oral or poster presentation. There is no need to submit an abstract twice.
Perspectives Sessions
provide both an expert review of recent advances and propose a road-map for the future,
incorporating multiple viewpoints to stimulate original discussion and debate. Perspectives Sessions should interest
and engage the core audience of the field being discussed, and also offer an entryway for attendees from other
fields. Perspectives Sessions can be invited by the Scientific Program Committee or submitted as an entire session.
Perspectives Sessions are 90 minutes in length and comprise 2 chairs and 4-6 presenters, with each presenter submitting a structured abstract that may or may not contain new findings, data or analyses.
The chairs of perspectives sessions are akin to senior authors of a review paper, who invite presenting authors to prepare individual sections of the review.
If a Perspectives Session is not accepted, abstracts are automatically considered by the SPC for an oral or poster presentation. There is no need to submit an abstract twice.
Clinical Toolbox Sessions
are educational sessions designed to enhance clinical knowledge, foster collaboration across disciplines and ensure that participants are informed of the latest advancements and best practices within their field. This initiative seeks to provide a holistic view of patient care, incorporating expertise across a range of clinical specialties including geriatricians, neurologists, neuropsychologists, nurses, primary care physicians and psychiatrists.
Clinical Toolbox Sessions are 90 minutes in length and comprise 2 chairs and 4-6 presenters, with each presenter submitting a structured abstract.
The scope is to provide education to clinicians on current practice, rather than insights into the latest research finding.
If a Clinical Toolbox Session is not accepted, abstracts are automatically considered by the SPC for an oral or poster presentation. There is no need to submit an abstract twice.
For all sessions, each chair and presenter may attend either in-person or virtually, with any combination of in-person and virtual attendance permitted. Unless the topic demands otherwise, the session should be diverse in terms of the demographics of presenters.
Submit an Abstract to a Preconference
Abstracts submitted to AAIC can also be submitted to the Alzheimer’s Imaging Consortium (AIC) or the
Technology and Dementia preconferences as part of the submission process. Please note, the AIC and the Technology and
Dementia preconferences take place in-person only and require an additional registration fee to AAIC.
Please submit the abstract to AAIC, and select the appropriate answer to the question "Should this abstract also be submitted to a pre-conference?" in the “Abstract Type” section of the submission process. The abstract will be considered for both
AAIC and the selected preconference.
Themes, Topics and Subtopics
Selection of a theme, topic and subtopic for the abstract allows submitters to "self-identify" the area
in which the abstract best fits. This identification is the first step in sorting abstracts for the Scientific Program Committee, who will take
this identification into consideration and group related abstracts with similar topics into the same session.
Selection of a primary theme, topic and subtopic is required.
You may also submit a case study to share your findings with the dementia research and clinical care community. Case studies present findings on a single individual and provide scientific considerations based on the case for the audience. They may describe a rare or unique clinical presentation, novel empirically-based course of treatment or treatment response, or instance when the outcome of a case did or did not fit with the current research literature.
AAIC 2027 THEMES, TOPICS AND SUBTOPICS
Theme: Basic Science & Pathogenesis
Topic: Genetics
Subtopics:
Case Study
Endophenotypes
Epigenetics
Genetic factors of Alzheimer’s disease
Genetic factors of non-Alzheimer’s disease
Genetics of cognitive aging
Genetics of systems biology
Transcriptomics
Topic: Human Neuropathology
Subtopics:
Alpha-synuclein
Amyloid
Case study
Clinico-pathologic correlations
Etiopathogenesis — links to brain disease
Imaging-pathologic correlations
Mixed pathology / comorbidities
Novel methods
Proteinopathies
Selective vulnerability
Tau
Topography of pathology
Vascular
Other
Topic: Molecular and Cell Biology
Subtopics:
Adaptive immunity
Alpha-synuclein
APP / Abeta / Amyloid
Endosomal-lysosomal dysfunction
Innate immunity
Lipids
Metabolic stress
Mitochondrial function / energetics
Neurodegeneration and neuroprotection
Neuroinflammation
Non-coding RNA
Oxidative stress
Presenilins
Prion-like
Protein-protein interactions
Proteostasis
Receptors / signal transduction
Synaptic disruption
Tau
TDP-43
Vascular factors
Other
Theme: Biomarkers
Topic: Biomarkers (Non-neuroimaging)
Subtopics:
Case study
Clinical trials
Differential diagnosis
Digital health technologies / digital biomarkers
Fluid biomarkers
Human neuropathology
Longitudinal
Method development and/or quality control
Mixed-pathology
Multi-modal comparisons
Neurophysiology / Neuromodulation
Novel biomarkers
Preclinical animal models
Prognostic utility
Topic: Neuroimaging
Subtopics:
Case study
Clinical trials
Differential diagnosis
Disease progression measures
Early detection measures
Evaluating treatments
Imaging and genetics
Longitudinal brain aging
Multi-modal comparisons
Novel imaging methods
Preclinical animal models
Theme: Clinical Manifestations
Topic: Neuropsychiatry and Behavioral Neurology
Subtopics:
Artificial intelligence / machine learning
Assessment and management of neurodegenerative disease
Join ISTAART, an inclusive global network of scientists, clinicians and dementia professionals. With newly discounted rates and free memberships for students, it’s easier than ever to become a part of ISTAART.